Press release
Antivirals Market Anticipated To Witness Robust Growth, Surpassing $153.67 Billion By 2029
Antivirals
What Is the Current Antivirals Market Size and Its Estimated Growth Rate?
The antivirals market has recorded strong growth over recent years, forecasted to grow from $106.13 billion in 2024 to $114.7 billion in 2025, at a CAGR of 8.1%. Factors behind past growth include the prevalence of viral illnesses, health-related concerns, patent expirations, and governmental support.
The antivirals market is anticipated to grow strongly in the near future. It will reach $153.67 billion by 2029 at a compound annual growth rate (CAGR) of 7.6%. This market expansion can be attributed to the emergence of new viral threats and global health initiatives. Key trends during this period include technological innovations, the rise of telemedicine and digital health solutions, and advancements in personalized medicine.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437
How Are Emerging Segments Shaping the Antivirals Market Landscape?
The antivirals market covered in this report is segmented -
1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications
Subsegments:
1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)
2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp
Which Growth Factors Are Influencing Antivirals Market Expansion?
The growing number of influenza cases is expected to support the expansion of the antiviral market. Influenza, a contagious respiratory illness caused by influenza viruses, affects the nose, throat, and lungs, and antivirals are crucial for treating it by hindering viral replication. For example, in October 2022, the Centers for Disease Control and Prevention reported that during the 2021-2022 season, there were 9 million flu cases, 4 million related medical visits, 100,000 hospitalizations, and 5,000 deaths in the US. Hence, the rising incidence of influenza is fueling the antiviral market's growth.
Who Are the Dominant Players Across Different Antivirals Market Segments?
Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.
What Are the Latest Developing Trends in the Antivirals Market?
Leading companies in the antiviral market are developing innovative oral antiviral treatments to enhance patient compliance, reduce TH*Care costs, and provide easier options for managing viral infections. In May 2023, Pfizer's Paxlovid, an oral treatment for COVID-19, was approved by the FDA. This approval marks a significant step in treating mild-to-moderate COVID-19 in high-risk adults and provides an alternative to more complex treatment regimens.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report
Which Geographic Regions Are Expected to Dominate the Antivirals Market in the Coming Years?
North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Antivirals Market?
2. What is the CAGR expected in the Antivirals Market?
3. What Are the Key Innovations Transforming the Antivirals Industry?
4. Which Region Is Leading the Antivirals Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antivirals Market Anticipated To Witness Robust Growth, Surpassing $153.67 Billion By 2029 here
News-ID: 4050963 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Antivirals
Increasing Incidence OF Influenza In The Antivirals Market: Pivotal Factor Influ …
"Increasing Incidence OF Influenza In The Antivirals Market: Pivotal Factor Influencing Antivirals Market Growth in 2025Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Antivirals Market Size Growth Forecast: What to Expect by 2025?
The size of the antivirals market has seen significant expansion in the past few years. The market is forecasted to increase from $106.13 billion…
Antivirals Market to Witness Promising Growth Opportunities by 2031
The Antivirals Market Global Industry Research Report is a comprehensive business study on the current state of the Antivirals Industry providing competitive analysis in form of 10 company profiles along with their product picture and specification, capacity production price cost production value and contact information says a latest report at The Insight Partners.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00007429?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Abbott Laboratories
Boehringer Ingelheim GmbH
Bristol-Myers-Squibb
Broad Institute
Hoffmann-La Roche
GlaxoSmithKline plc.
Johnson…
Unlocking Potential: Topical Antivirals Market Impact on Market Dynamics
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market research firm, has recently published a comprehensive report on the 𝐓𝐨𝐩𝐢𝐜𝐚𝐥 𝐀𝐧𝐭𝐢𝐯𝐢𝐫𝐚𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭. This report aims to provide a complete overview of the market, offering the latest updated information on various crucial aspects that are expected to impact Market trends and performance during the forecast period.
𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐓𝐨𝐩𝐢𝐜𝐚𝐥 𝐀𝐧𝐭𝐢𝐯𝐢𝐫𝐚𝐥𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 https://growthmarketreports.com/request-sample/6103
𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐓𝐨𝐩𝐢𝐜𝐚𝐥 𝐀𝐧𝐭𝐢𝐯𝐢𝐫𝐚𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭:
𝐁𝐲 𝐓𝐲𝐩𝐞…
Revolutionizing the Antivirals Market: A Comprehensive Overview
The antivirals market has experienced robust growth, surging from $97.72 billion in 2023 to an estimated $105.73 billion in 2024, exhibiting an impressive Compound Annual Growth Rate (CAGR) of 8.2%. Projections indicate continued expansion, with the market anticipated to reach $143.83 billion by 2028, sustaining a CAGR of 8.0%.
Drivers of Growth:
The escalating incidence of influenza stands as a primary driver for the unprecedented growth of the antivirals market. Antivirals play…
Antivirals Market will reach 60200 million US$ in 2023
New report published by Global Info Research which offers insights on the global Antivirals market.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development. …
Antivirals Market: Latest Trends,Analysis & Insights 2024
Global Antivirals Market: Overview
An antiviral is an agent that eliminates a virus or restrains its ability to multiply and hence, prevents it from replicating and reproducing. Antiviral drugs are used in the treatment of lethal viral infections such as HIV, hepatitis B and C viruses, influenza A and B viruses, and herpes viruses. According to WHO, 36.7 million people were living with HIV at the end of 2015.
Although the development…
